FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 143 filers reported holding FLEXION THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,000 | +50.0% | 1,963 | +103.8% | 0.00% | – |
| Q2 2021 | $8,000 | -100.0% | 963 | -77.6% | 0.00% | – |
| Q1 2021 | $38,486,000 | +427522.2% | 4,300 | +469.5% | 0.00% | – |
| Q4 2020 | $9,000 | -18.2% | 755 | -28.4% | 0.00% | – |
| Q3 2020 | $11,000 | -21.4% | 1,055 | 0.0% | 0.00% | – |
| Q2 2020 | $14,000 | +75.0% | 1,055 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -61.9% | 1,055 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $21,000 | +50.0% | 1,055 | 0.0% | 0.00% | – |
| Q3 2019 | $14,000 | +16.7% | 1,055 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -42.9% | 1,055 | -5.1% | 0.00% | -100.0% |
| Q3 2018 | $21,000 | -72.4% | 1,112 | -62.2% | 0.00% | -80.0% |
| Q2 2018 | $76,000 | +38.2% | 2,942 | +19.3% | 0.01% | +25.0% |
| Q1 2018 | $55,000 | -9.8% | 2,467 | 0.0% | 0.00% | -20.0% |
| Q4 2017 | $61,000 | +48.8% | 2,467 | +43.0% | 0.01% | +25.0% |
| Q3 2017 | $41,000 | +583.3% | 1,725 | +475.0% | 0.00% | +300.0% |
| Q2 2017 | $6,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
| MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
| Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
| Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
| CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
| Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
| SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
| AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
| Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |